1 ... 3 4 5 6 7 Showing 301 to 328 of 328 trials. Show trials.
Print List Download
 
Trial Name Trial ID Main Coordinating Centre
and contact		 Status Recruitment Topic Participants Details
TIPPS - Thrombophilia in pregnancy prophylaxis study: a multicentre, multinational, randomised controlled trial of prophylactic low molecular weight heparin in high-risk pregnant thrombophilic women ISRCTN87441504 The University of Ottawa Hospital, Ontario, Canada, Professor Marc Rodger (Chief Investigator). Suzette Coat - Australian Coordinator Recruitment complete Preeclampsia. Fetal growth Pregnant women with thrombophilia at increased risk of venous thromboembolism or with previous placenta mediated pregnancy complication prior to 20 weeks gestation
HATCh - The effects of antenatal hypnosis on pain relief in labour ACTRN12605000018617 / NCT00282204 Women's & Children's Hospital Allan Cyna Recruitment complete Labour and intrapartum care Previous hypnosis for childbirth; woman definitely wants an epidurtal or hypnosis; Not singleton live fetus before 34 weeks gestation; Other conditions causing pain; Active psychiatric illness.
PPROMT - Immediate delivery vs expectant care in women with preterm prelabour rupture of the membranes close to term - A randomised clinical trial PT0536/ISRCTN44485060/NHMRC358378 Dept of Obstetrics & Gynaecology, Royal North Shore Hospital ppromt@med.usyd.edu.au Recruitment complete Preterm birth ? improving outcomes (antenatal interventions) Singleton pregnancies, with confirmed ruptured membranes from 34 weeks to 36 weeks and 6 days gestation.
MILO - Oral misoprostol for the induction of labour at term PT0361/ACTRN012606000156583 Women's and Children's Hospital , SA jodie.dodd@adelaide.edu.au Recruitment complete Labour and intrapartum care Singleton pregnancy, at a gestational age of 37 weeks or more, planned induction of labour for defined obstetric and medical conditions - prolonged pregnancy, pre-eclampsia, hypertensive disoreders, antepartum haemorrhage (ecluding placenta praevia), oligohydramnios, IUGR, or abnormal glucose tolerance.
A double-blind randomised controlled trial of oxytocin bolus plus placebo infusion versus oxytocin bolus plus oxytocin infusion at elective caesarean section ACTRN12607000631404 Monash Medical Centre joanne.mockler@med.monash.edu.au Discontinued Labour and intrapartum care Singleton pregnancy, gestation 37 - 41 weeks, elective lower segment caesarean section, regional anaesthesia (spinal, epidural, combined spinal epidural (CSE))
ACTORDS - Australasian Collaborative Trial of Repeat Doses of Corticosteroids for the Prevention of Neonatal Respiratory Disease ACTRN12606000318583; PT0349; ISRCTN48656428 Adelaide Women's and Children's
pat.ashwood@adelaide.edu.au		 Recruitment complete Preterm birth improving outcomes (antenatal interventions). Newborn respiratory Singleton, twin or triplet pregnancy at less than 32 weeks gestation; 7 or more days since first corticosteroid treatment, remaining at risk of preterm delivery
Twin birth study (TBS): a multicentred randomised controlled trial comparing planned caesarean section with planned vaginal birth for twins at 32-38 weeks gestation PT0540/ISRCTN74420086/ACTRN12606000267550 University of Toronto Dalah Mason Recruitment complete Labour and intrapartum care Twins where twin A is cephalic, gestational age 32-38 weeks, estimated fetal weight 1500-4000g, both twins alive.
Oral misoprostol versus intravenous oxytocin for induction of labour following artificial or spontaneous rupture of membranes jodie.dodd@adelaide.edu.au Recruitment complete Labour and intrapartum care Women > or = 41 weeks booked for delivery at Women's and Children's Hospital; singleton pregnancy; cephalic presentation
The influence of acupuncture on the induction of labour for women with a post date pregnancy: a randomised controlled trial. PT0348 / ACTRN12606000494538 caroline.smith@uws.edu.au Recruitment complete Labour and intrapartum care Women > or = 41 weeks; singleton pregnancy; cephalic presentation
HUGS - Early intervention to protect the mother-infant relationship following postnatal depression - a randomised controlled trial ACTRN12612001110875 Parent-Infant Research Institute, Austin Health, (03) 9496 4496, piri@austin.org.au
 Recruitment complete Postnatal depression, mother-infant interaction Women aged 18 years or older with an infant aged 3-9 months and a clinical diagnosis of current major or minor depressive episode
USES Trial - Women's Opinions and Experiences of Prenatal Screening for Down Syndrome PT0355 caroline.crowther@adelaide.edu.au Recruitment complete Fetal surveillance. Fetal anomaly Women at less than 14 weeks gestation who have not had a dating scan or nuchal translucency screening
IRIS - A randomised clinical trial of different infusion rates of magnesium sulphate given prenatally to women for the prevention of side effects ACTRN12605000765628 Women's and Children's Hospital, SA caroline.crowther@adelaide.edu.au Recruitment complete Preterm birth ? improving outcomes (antenatal interventions) Women at less than 30 weeks gestation where birth is planned or definitely expected within 24 hours.
A*STEROID - Australasian Antenatal Study to Evaluate the Role Of Intramuscular Dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability - a randomised controlled trial ACTRN12608000631303 The University of Adelaide / Women's & Children's Hospital pat.ashwood@adelaide.edu.au Recruitment complete Preterm birth ? improving outcomes (antenatal interventions). Newborn respiratory Women at risk of preterm birth at less than 34 weeks gestation, have a singleton or twin pregnancy and no contraindications to the use of antenatal corticosteroids
IDEAL - Dietary and Lifestyle advice for women with borderline gestational glucose intolerance ACTRN12607000174482 Australian Research Centre for Health of Women and Babies (ARCH), The University of Adelaide pat.ashwood@adelaide.edu.au Recruitment complete Diabetes. Maternal nutrition Women between 24 weeks 0 days and 34 weeks 6 days gestation with a singleton pregnancy, with a positive OGCT (venous plasma glucose >=7.8 mmol/L) and a normal 75 gram OGTT (fasting venous plasma glucose <5.5 mmol/L and a 2 hour glucose <7.8 mmol/L),
CLOSURE - Skin and subcutaneous fascia closure at caesarean section: a randomised controlled trial ACTRN12608000143325 Discipline of Obstetrics and Gynaecology, Women's and Children's Hospital rosalie.grivell@adelaide.edu.au Recruitment complete Labour and intrapartum care Women undergoing a caesarean section by transverse suprapubic incision
MPG Trial - Metformin in the Prevention of Gestational Diabetes ACTRN12610000157077 Women`s and Children`s Hospital, Children`s Youth and Women`s Health Service, North Adelaide suzette.coat@adelaide.edu.au Discontinued Prevention of recurrent Gestational diabetes Women who have had a previous pregnancy affected by GDM
Help-seeking for postnatal depression as a major public health problem: A cluster randomised controlled trial of motivational interviewing ACTRN12611000635965 Parent-Infant Research Institute, Austin Health, (03) 9496 4496, piri@austin.org.au
 Recruitment complete Motivational interviewing, postnatal depression Women with a 4-week old baby
BAC - Birth after Caesarean. Planned vaginal birth or planned caesarean section for women at term with a single previous caesarean birth ISRCTN53974531/NHMRC349460 Maternal Perinatal Clinical Trials Unit, Adelaide Women's and Children's
Pat Ashwood		 Recruitment complete Labour and intrapartum care Women with a single prior caesarean presenting in their next pregnancy with a single live fetus in cephalic presentation who have reached 37 weeks gestation, and who don't have a contraindication to a planned VBAC.
Improving oral hygiene to reduce the risk of preterm birth: A randomised controlled trial assessing a high intensity educational intervention ACTRN12605000767606 caroline.crowther@adelaide.edu.au Discontinued Preterm birth ? prevention and treatment Women with a singleton pregnancy
ACTOTTAB - Twins: Timing of birth at Term PT0426/ISRCTN15761056 WCH, Adelaide Jodie Dodd Recruitment complete Labour and intrapartum care. Models of care Women with a twin pregnancy at 37 weeks gestation
DIAMIND - Diabetes SMS text reminders versus standard care for women who have had gestational diabetes mellitus to increase the rate of oral glucose testing in the postpartum period ACTRN12612000621819 Australian Research Centre for Health of Women & Babies, The University of Adelaide emer.heatley@adelaide.edu.au Recruitment complete Diabetes. Maternal medical conditions Women with GDM in current pregnancy, singleton or twin pregnancy, with access to a mobile phone, postnatal blood glucose that level returned to normal before discharge
STRIDER (NZAus)- A randomised placebo-controlled trial of a new therapy (sildenafil) to help growth in severely growth restricted fetuses at very early gestations ACTRN12612000584831 Department of Obstetrics and Gynaecology, University of Auckland Laura Mackay (Trial Manager) laura.mackay@auckland.ac.nz; Dr Katie Groom (Chief Investigator) k.groom@auckland.ac.nz Recruitment complete
IMPACT reviewed
 Fetal growth. Preeclampsia. Pterterm birth - prevention and treatment Women with pregnancies complicated early onset fetal growth restriction. Abdominal circumference ≤3rd centile at 22-28 weeks or EFW <700g at 28-80 weeks
PLUTO - Percutaneous shunting for lower urinary tract obstruction ISRCTN53328556 The Clinical Trials Unit, University of Birmingham. Professor Mark Kilby (Chief Investigator) m.d.kilby@bham.ac.uk Recruitment complete Fetal anomaly women with pregnancy with a male fetus complicated by isolated lower urinary tract obstruction (LUTO)
EPPI Trial - Enoxaparin for the Prevention of Preeclampsia and Intrauterine growth restriction ? a pilot randomised placebo-controlled trial ACTRN12609000699268 Department of Obstetrics and Gynaecology, University of Auckland. Laura Mackay (Trial Manager) laura.mackay@auckland.ac.nz; Dr Katie Groom (Chief Investigator) k.groom@auckland.ac.nz Recruitment complete
IMPACT reviewed
 Fetal growth. Preeclampsia Women with previous pregnancy complicated by early onset preeclampsia or fetal growth restriction
FRUIT-Study - Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia ISRCTN87325378 Department of Obstetrics and Gynaecology, VU University Medical Center, Amsterdam,
Netherlands.
Prof JIP de Vries (Chief Investigator) jip.devries@vumc.nl		 Recruitment complete Preeclampsia. Fetal growth. Maternal medical conditions women with previous pregnancy with hypertensive disease and/or SGA <34 weeks and an inheritable thrombophilia
HEPRIN - Heparin for the Prevention of complications related to placental Insufficiency ISRCTN88675588 Mt Sinai Hospital, Professor Jodie Dodd (Principal Investigator) jodie.dodd@adelaide.edu.u Recruitment complete Preeclampsia. Fetal growth Women with significant risk factors for placental insufficiency (low PAPP-A, high AFP, high inhibin, high hCG, medical and obstetric risk factors or abdnormal uterine artery Doppler)
NIFTY - A multi-centre randomised double blind placebo controlled trial of nifedipine maintenance tocolysis in fetal fibronectin positive women in threatened preterm labour ACTRN12613000985785 National Women's Health, Auckland Hospital. Dr Emma Parry (Principal Investigator) EmmaP@adhb.govt.nz Recruitment complete Preterm birth ? prevention and treatment Women with threatened preterm labour, a singleton pregnancy, gestational age between 24 and 34 weeks, intact membranes, positive fetal fibronectin test, completed course of corticosteroids
Open versus specific questioning to assess pain during anaesthetic follow-up after caesarean birth: a randomised trial ACTRN12609000121268 Women's & Children's Hospital Allan Cyna Recruitment complete Labour and intrapartum care Women within 72 hour of their caesarean section